Rockwell Medical (RMTI) EBITDA Margin (2010 - 2026)
Rockwell Medical's (RMTI) quarterly EBITDA Margin came in at 5.97% in Q2 2026, up 243.0% on a YoY basis from 1.74% in Q2 2025, and up 30.1% quarter-over-quarter from 8.54% in Q1 2026.
Powered by 
Analysis
Rockwell Medical (RMTI) EBITDA Margin (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has reported EBITDA Margin for 17 consecutive years, with 5.97% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin rose 243.0% year-over-year to 5.97%; the trailing twelve-month figure through Jun 2026 stood at 6.52% (down 505.0% YoY), and the FY2025 full-year result was 6.77%, down 737.0% from the prior year.
- EBITDA Margin improved to 5.97% in Q2 2026 per RMTI's latest filing, from 8.54% in the prior quarter.
- Across five years, EBITDA Margin topped out at 6.84% in Q3 2024 and bottomed at 41.09% in Q1 2022.
- Historically, EBITDA Margin has averaged 9.43% across 5 years, with a median of 7.28% in 2023.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin surged 4434 bps in 2022, then slumped 1678 bps in 2025.
- Over 5 years, EBITDA Margin stood at 10.18% in 2022, then jumped by 76 bps to 2.48% in 2023, then climbed by 15 bps to 2.1% in 2024, then dropped by 3 bps to 2.17% in 2025, then tumbled by 175 bps to 5.97% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 5.97%, 8.54%, and 2.17% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 13.31% |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 5.14% |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 20.53% |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 7.33% |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 12.93% |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 10.89% |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -5.97% |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -71.46% |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.97% |
| Mar 31, 2026 | -8.54% |
| Dec 31, 2025 | -2.17% |
| Sep 30, 2025 | -9.95% |
| Jun 30, 2025 | -8.39% |
| Mar 31, 2025 | -7.19% |
| Dec 31, 2024 | -2.10% |
| Sep 30, 2024 | 6.84% |
| Jun 30, 2024 | 1.99% |
| Mar 31, 2024 | -5.84% |
| Dec 31, 2023 | -2.48% |
| Sep 30, 2023 | -7.31% |
| Jun 30, 2023 | -16.37% |
| Mar 31, 2023 | -7.26% |
| Dec 31, 2022 | -10.18% |
| Sep 30, 2022 | -19.84% |
| Jun 30, 2022 | -23.99% |
| Mar 31, 2022 | -41.09% |
| Dec 31, 2021 | -54.52% |
| Sep 30, 2021 | -43.61% |